Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant To Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported): March 29, 2005

 

 

ANGIODYNAMICS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

0-50761   11-3146460
(Commission File Number)   (IRS Employer Identification No.)

 

603 Queensbury Avenue, Queensbury, New York   12804
(Address of Principal Executive Offices)   (Zip Code)

 

(518) 798-1215

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

ITEM 7.01 REGULATION FD DISCLOSURE

 

The following information is furnished pursuant to both Item 2.02 and Item 7.01

 

On March 29, 2004, AngioDynamics, Inc. hosted a conference call by telephone and internet access to discuss its financial results for the thirteen and thirty-nine weeks ended February 26, 2005. A transcript of the conference call is attached hereto as Exhibit 99.1 and is incorporated herein by reference in its entirety.

 

The information in this Form 8-K and the Exhibit attached hereto shall not be deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

  (c) Exhibits
99.1    Transcript of conference call held on March 29, 2005, discussing financial results for the thirteen and thirty-nine weeks ended February 26, 2005.

 

2

SIGNATURES:

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: March 30, 2005

  

ANGIODYNAMICS, INC.

   

(Registrant)

   

By:

  

/s/ Joseph G. Gerardi

       

Joseph G. Gerardi

       

Vice President, Chief Financial Officer

 

3

EXHIBIT INDEX

 

Exhibit
   

Description

99.1    Transcript of conference call held on March 29, 2005 discussing financial results for the thirteen and thirty-nine weeks ended February 26, 2005.

 

4